You are here

  • Home
  • Archive
  • Volume 69, Issue 10
  • Are switches from oral to subcutaneous methotrexate or addition of ciclosporin to methotrexate useful steps in a tight control treatment strategy for rheumatoid arthritis? A post hoc analysis of the CAMERA study

Article info

Article menu
Download PDFPDF
Clinical and epidemiological research
Concise report
Are switches from oral to subcutaneous methotrexate or addition of ciclosporin to methotrexate useful steps in a tight control treatment strategy for rheumatoid arthritis? A post hoc analysis of the CAMERA study

Authors

  1. Correspondence to M F Bakker, Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, F02.127, PO Box 85500, Utrecht 3508 GA, The Netherlands; m.f.bakker-4{at}umcutrecht.nl
View Full Text

Citation

Bakker MF, Jacobs JWG, Welsing PMJ on behalf of the Utrecht Arthritis Cohort Study Group, et al
Are switches from oral to subcutaneous methotrexate or addition of ciclosporin to methotrexate useful steps in a tight control treatment strategy for rheumatoid arthritis? A post hoc analysis of the CAMERA study
Annals of the Rheumatic Diseases 2010;69:1849-1852.

Publication history

  • Accepted April 5, 2010
  • First published May 28, 2010.
Online issue publication 
October 25, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions